Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
TNF Pharmaceuticals Logo
TNF Pharmaceuticals Growth Score
68
CB Rank
180892
Heat Score
51
TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.
Founded
obfuscation
PublicPost-IPO Equity Baltimore, Maryland, United States1-10 tnfpharma.com/
Biotechnology
Clinical Trials
Pharmaceutical
Overview

TNF Pharmaceuticals
Total Funding
obfuscation
Growth Score
68
Heat Score
51

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score68
-9 pts
in past quarter
Heat Score 51
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About TNF Pharmaceuticals

CB Rank
180892
TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.
Founded
obfuscation
PublicPost-IPO Equity Baltimore, Maryland, United States1-10 tnfpharma.com/
Biotechnology
Clinical Trials
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Jenna Brager
    Jenna Brager: Vice President of Drug Development
    Past Role: LifeBridge Health, Director of Clinical Research and Scientific Grants
  • Photo of Jude Uzonwanne
    Jude Uzonwanne: Member Board Of Directors
    Past Role: IQVIA, Principal

Details

Legal Name TNF Pharmaceuticals, Inc
Also Known As MyMD Pharmaceuticals
Operating Status Active
Stock Symbol  NASDAQ:TNFA
Company Type For Profit
About the Company
TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.
Phone Number +1 813) 864-2566
Contact Email info@mymd.com
Predictions & Insights

Growth Insight

See this Growth Insight
TNF Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

MYMD-1
An orally available TNF-alpha inhibitor designed to regulate the immune system, reduce chronic inflammation, and potentially treat autoimmune diseases and age-related conditions.
Supera-CBD
A synthetic cannabidiol analog that targets CB2 receptors, developed to manage anxiety, chronic pain, seizures, and potentially addiction, with higher potency and bioavailability than plant-derived CBD.

Research & Development

TNF Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
PharmaCyte Biotech Logo
PharmaCyte Biotech
Yes
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
PharmaCyte Biotech Logo
PharmaCyte Biotech
Yes
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
PharmaCyte Biotech Logo
PharmaCyte Biotech
Yes
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
PharmaCyte Biotech Logo
PharmaCyte Biotech
Yes
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—
PharmaCyte Biotech Logo
PharmaCyte Biotech
Yes
Post-IPO Equity - TNF Pharmaceuticals Logo
Post-IPO Equity - TNF Pharmaceuticals
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4

Employee Profiles

News

News and Press

News•Sep 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,176
1,766.67%
 in past month

IT Spend

$44KThis year, TNF Pharmaceuticals is projected to spend $44K on IT, according to Aberdeen.

Active Website Tech Count

10TNF Pharmaceuticals is actively using 10 technologies for its website, according to BuiltWith. These include HSTS, Content Delivery Network, and  Apache.
Sub-Organizations
Frequently Asked Questions

Where is TNF Pharmaceuticals's headquarters? TNF Pharmaceuticals is located in Baltimore, Maryland, United States.Who invested in TNF Pharmaceuticals? TNF Pharmaceuticals is funded by PharmaCyte Biotech.When was the last funding round for TNF Pharmaceuticals? TNF Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has TNF Pharmaceuticals raised to date? TNF Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|